Cargando…

Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening

BACKGROUND: The SureX HPV genotyping test (SureX HPV test), which targets the human papillomavirus (HPV) E6/E7 genes was compared with the Cobas 4800 and Venus HPV tests for detecting 14 high-risk HPV (HR-HPV) types in clinical referral and follow-up patients to evaluate its value for cervical cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Baojun, Mei, Ping, Huang, Shengkai, Yu, Xueting, Zhi, Tong, Wang, Guojing, Xu, Xiaotian, Xiao, Lin, Dong, Xin, Cui, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650185/ https://www.ncbi.nlm.nih.gov/pubmed/33168022 http://dx.doi.org/10.1186/s12985-020-01417-8

Ejemplares similares

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
por: Chua, Brandon Wen Bing, et al.
Publicado: (2022)

Need for expanded HPV genotyping for cervical screening()
por: Cuzick, Jack, et al.
Publicado: (2016)

HPV negative cervical cancers and primary HPV screening
por: Tjalma, WAA
Publicado: (2018)

Evaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening
por: BIAN, MEI-LU, et al.
Publicado: (2013)

HPV16/18 genotyping for the triage of HPV positive women in primary cervical cancer screening in Chile
por: Lagos, Marcela, et al.
Publicado: (2015)

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
por: Agorastos, Theodoros, et al.
Publicado: (2015)

HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples
por: Cornall, Alyssa M., et al.
Publicado: (2017)

Detection of cervical precancerous lesions with Aptima HPV assays using SurePath preservative fluid specimens
por: Chernesky, Max, et al.
Publicado: (2017)

Comparison of the Cepheid Xpert HPV test and the HC2 High-Risk HPV DNA Test for detection of high-risk HPV infection in cervical smear samples in SurePath preservative fluid
por: Rabaan, Ali A., et al.
Publicado: (2018)

HPV genotype distribution according to severity of cervical neoplasia using the digene HPV genotyping LQ test
por: Halfon, Philippe, et al.
Publicado: (2013)

PCR and Genotyping for HPV in Cervical Cancer Patients
por: Prakash, Pradyot, et al.
Publicado: (2016)

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2020)

Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework
por: Bonde, Jesper Hansen, et al.
Publicado: (2020)

Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening
por: Hashim, Dana, et al.
Publicado: (2020)

HPV and cervical cancer: screening or vaccination?
por: Bosch, F X, et al.
Publicado: (2008)

The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
por: Ejegod, Ditte, et al.
Publicado: (2016)

Cytological Evaluation and REBA HPV-ID HPV Testing of Newly Developed Liquid-Based Cytology, EASYPREP: Comparison with SurePath
por: Lee, Youn Soo, et al.
Publicado: (2013)

Telomere length in cervical exfoliated cells, interaction with HPV genotype, and cervical cancer occurrence among high‐risk HPV‐positive women
por: Chen, Xiaojun, et al.
Publicado: (2019)

Genotype-specific methylation of HPV in cervical intraepithelial neoplasia
por: Hsu, Yaw-Wen, et al.
Publicado: (2017)

Cervical cancer screening and HPV genotype distribution among asymptomatic patients of Karachi Pakistan
por: Shahid, Mubeena, et al.
Publicado: (2015)

HPV vaccination bridges to HPV screening
por: Harper, Diane M, et al.
Publicado: (2020)

Cervical Cancer Screening and HPV Vaccination in Nepal
por: Baral, Gehanath, et al.
Publicado: (2023)

Prevalence of human papilloma virus (HPV) and its genotypes in cervical specimens of Egyptian women by linear array HPV genotyping test
por: Youssef, Mohamed A., et al.
Publicado: (2016)

Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples
por: Avian, Alice, et al.
Publicado: (2022)

HPV genotypes in paraffin sections of non-cervical squamous cell carcinoma in Qingdao of China
por: DI GAO, ZHI, et al.
Publicado: (2013)

Diagnostic sensitivity for invasive cervical carcinoma of high risk HPV tests performed on SurePath™ liquid-based pap specimens
por: Nance, Keith V
Publicado: (2013)

Comparison of the performance of HPV DNA chip test and HPV PCR test in cervical cancer screening in rural China
por: Li, Zhi-Fang, et al.
Publicado: (2022)

Projected impact of HPV vaccination and primary HPV screening on cervical adenocarcinoma: Example from Australia
por: Smith, Megan A., et al.
Publicado: (2017)

HPV genotype distribution and anomalous association of HPV33 to cervical neoplastic lesions in San Luis Potosí, Mexico
por: DelaRosa-Martínez, Raúl, et al.
Publicado: (2016)

Correction: Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples
por: Avian, Alice, et al.
Publicado: (2023)

Global availability of data on HPV genotype-distribution in cervical, vulvar and vaginal disease and genotype-specific prevalence and incidence of HPV infection in females
por: Wagner, Monika, et al.
Publicado: (2015)

HPV-EM: an accurate HPV detection and genotyping EM algorithm
por: Inkman, Matthew J., et al.
Publicado: (2020)

The effectiveness of HPV viral load, reflected by Cobas 4800 HPV-Ct values for the triage of HPV-positive women in primary cervical cancer screening: Direct endocervical samples
por: Duan, Lyufang, et al.
Publicado: (2020)

Dynamics of genotype-specific HPV clearance and reinfection in rural Ghana may compromise HPV screening approaches
por: Krings, Amrei, et al.
Publicado: (2019)

Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore
por: Chua, Brandon, et al.
Publicado: (2023)

HPV-genotyping versus conventional cervical cytology as a screening method to detect dysplastic cervical epithelial changes
por: Abbas, Mahmoud, et al.
Publicado: (2022)

Distribution of HPV genotypes in cervical intraepithelial lesions and cervical cancer in Tanzanian women
por: Vidal, Adriana C, et al.
Publicado: (2011)

Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana
por: Obiri-Yeboah, Dorcas, et al.
Publicado: (2017)

Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16(INK4a) immunostaining in China
por: Song, Fangbin, et al.
Publicado: (2021)

Characteristics of carcinogenic HPV genotypes in North China Plain and the association with cervical lesions
por: Liu, Lihua, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3252pok5j2uf7d88r7nc9mlgaf